PMID- 36942312 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230322 IS - 2473-1242 (Electronic) IS - 2473-1242 (Linking) VI - 7 IP - 1 DP - 2023 TI - Nondisparate Survival of Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect of Access to and Provision of Care Within a Military Health Care System. PG - 178-184 LID - 10.1089/heq.2022.0128 [doi] AB - INTRODUCTION: Breast cancer mortality rates are 40% higher in non-Hispanic Blacks (NHBs) than in non-Hispanic White (NHWs) in the United States. All women treated within the Murtha Cancer Center at Walter Reed National Military Medical Center (MCC/WRNMMC) have health insurance and are provided multidisciplinary health care. Pathological factors and outcomes of NHBs and NHWs treated within the MCC/WRNMMC were evaluated to determine whether equal-access health care reduces disparate phenotypes and survival between the racial groups. METHODS: Between 2001 and 2018, 368 NHB and 819 NHW women were diagnosed with breast cancer at MCC/WRNMMC. Differences between NHBs and NHWs in epidemiological and pathological characteristics were evaluated. Overall and breast cancer-specific 5- and 10-year survival rates were compared between races. RESULTS: Compared with NHWs, NHBs were significantly more likely to have a body mass index >/=30 kg/m(2), to be unmarried, to have tumors of higher grade, later stage, with lymph node metastases, and to be hormone receptor negative (HR(-))/human epidermal growth factor receptor 2 positive (HER2(+)) or triple negative. After adjustment for demographic factors, NHBs remained significantly more likely to have tumors diagnosed at a higher grade and later stage, and to be HR(-)/HER2(+) or triple negative. Neither 5- nor 10-year overall or breast cancer-specific survival differed significantly between the racial groups after adjusting for demographic and pathological variables. DISCUSSION: Despite having tumors with less favorable pathological characteristics, overall and disease-free survival disparities were not observed for NHBs treated at MCC/WRNMMC. These data suggest that survival disparities of NHBs with breast cancer can be diminished with provision of quality care. CI - (c) Sarah Darmon et al., 2023; Published by Mary Ann Liebert, Inc. FAU - Darmon, Sarah AU - Darmon S AD - Murtha Cancer Center/Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland, USA. FAU - Lovejoy, Leann A AU - Lovejoy LA AD - Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, Pennsylvania, USA. FAU - Shriver, Craig D AU - Shriver CD AD - Murtha Cancer Center/Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland, USA. AD - Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. FAU - Zhu, Kangmin AU - Zhu K AD - Murtha Cancer Center/Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland, USA. AD - Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. AD - Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. AD - Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA. FAU - Ellsworth, Rachel E AU - Ellsworth RE AUID- ORCID: 0000-0003-2287-1635 AD - Murtha Cancer Center/Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland, USA. AD - Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA. LA - eng PT - Journal Article DEP - 20230310 PL - United States TA - Health Equity JT - Health equity JID - 101708316 PMC - PMC10024578 OTO - NOTNLM OT - Black OT - breast cancer OT - disparities OT - pathology OT - survival COIS- No competing financial interests exist. EDAT- 2023/03/22 06:00 MHDA- 2023/03/22 06:01 PMCR- 2023/03/10 CRDT- 2023/03/21 02:19 PHST- 2022/12/29 00:00 [accepted] PHST- 2023/03/21 02:19 [entrez] PHST- 2023/03/22 06:00 [pubmed] PHST- 2023/03/22 06:01 [medline] PHST- 2023/03/10 00:00 [pmc-release] AID - 10.1089/heq.2022.0128 [pii] AID - 10.1089/heq.2022.0128 [doi] PST - epublish SO - Health Equity. 2023 Mar 10;7(1):178-184. doi: 10.1089/heq.2022.0128. eCollection 2023.